European migration crises: The role of national hemoglobinopathy registries in improving patient access to care

1Department of PaediatricHaematology, Evelina LondonChildren’sHospital, Guy’s and St ThomasNHSTrust, London, UnitedKingdom 2Clinic of PediatricHematologyOncology, Department of Child andMaternal Health, AziendaOspedaliera-Università di Padova, Italy Correspondence BabaP.D. Inusa,DepartmentofPaediatricHaematology, Evelina LondonChildren’sHospital,Guy’s andStThomasNHSTrust, LondonSE17EH,UnitedKingdom. Email: baba.inusa@gstt.nhs.uk

[1]  Á. Cervera,et al.  National registry of hemoglobinopathies in Spain (REPHem) , 2017, Pediatric blood & cancer.

[2]  M. Hulihan,et al.  State-based surveillance for selected hemoglobinopathies , 2014, Genetics in Medicine.

[3]  R. Petrova-Benedict,et al.  Haemoglobinopathies in Europe: health & migration policy perspectives , 2014, Orphanet Journal of Rare Diseases.

[4]  A. Tatem,et al.  Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000 , 2014, The Lancet. Global health.

[5]  R. Latinovic,et al.  Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005–7 , 2008, Journal of Clinical Pathology.

[6]  D J Weatherall,et al.  Inherited haemoglobin disorders: an increasing global health problem. , 2001, Bulletin of the World Health Organization.

[7]  Matthew W. Darlison,et al.  A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom. , 2001, Bulletin of the World Health Organization.

[8]  K. Nicolaides,et al.  Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years , 1997, BMJ.

[9]  J. Mann.  Sickle cell haemoglobinopathies in England. , 1981, Archives of disease in childhood.

[10]  R. Huntsman.  Hemoglobinopathies: how big a problem? , 1978, Canadian Medical Association journal.